INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Digital Endpoint Resource Guide: Parkinson's Disease

  Explore how sensor-based digital health technologies can revolutionize the treatment and management of movement disorders by providing more accurate, patient-centered outcomes.

• Looking Beyond Weight Loss In The Obesity Pandemic: What's Next?

  Here, we analyze the current landscape of obesity management, underscoring the critical need for comprehensive approaches that prioritize overall well-being beyond simple weight reduction.

• Outlook 2025: Key Trends & Insights

  Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.

• Guide: How Connected Devices Improve Clinical Trial Data

  Gain an overview of how and why connected devices provide sponsors and CROs with better clinical trial data, and offer patients much better trial experiences!

• Scout Belongs In Your eClinical Solution Suite

  9/3/2025

  Traditional eClinical platforms manage data, but not participation. Learn how to fill the gap with travel, payments, and support that keep patients engaged, sites focused, and trials moving forward.

• Proving The Return On Investment For eRegulatory

  1/22/2025

  Explore a study of how leading research centers, CROs, and sponsors cover the cost of eRegulatory tools … and then some.

• Sanofi's Take On The Evolving Role Of AI In Clinical Trials

  10/29/2025

  Matthew Peruhakal, Global Head of Data Architecture, Utilization, and AI Engineering at Sanofi, offers a deep look at how the pharmaceutical giant is integrating AI to transform clinical trials.

• Citeline SmartSolutions

  11/11/2024

  Citeline SmartSolutions is a new generation of AI-powered clinical solutions including tools to recommend primary endpoints and inclusion/exclusion criteria and instantly generate a list of protocol-matched investigators for your trial.

• Beyond Help Desk: RTSM Support Ready For Change

  3/25/2026

  This clip explores what sponsors should expect from an RTSM support model built for long‑term study needs, emphasizing capacity, flexibility, and readiness to adapt as trials evolve.